Skip to main content

Table 2 Comparison of genotyping of VEGFA−634G/C (rs2010963) polymorphism and serum levels of VEGF between patients and control

From: Study of single nucleotide polymorphism of vascular endothelium factor in patients with differentiated thyroid cancer

 

Patients (n = 70)

Control (n = 70)

P

VEGF (mean ± SD)

1215.81 ± 225.78

307.16 ± 91.81

0.000*

VEGF Genotypes (N0.-%)

 CC

37 (52.9%)

53 (75.7%)

0.006**

 CG

20 (28.6%)

14 (20.0%)

 GG

13 (18.6%)

3 (4.3%)

C

94/140 (67.1%)

120/140 (85.7%)

0.001**

G

46/140 (32.9%)

20/140 (14.3%)

 
  1. *ANOVA test p significant <0.05, **Chi-square test p significant <0.05